Jul242012
July 2012—British drug giant GlaxoSmithKline has agreed to pay a multibillion-dollar fine for civil andcriminal fraud, making it the largest and costliest health care lawsuit in U.S. history. Now the company is ducking and weaving but promising better transparency and harsher punishment for any shenanigans going forward. The question is whether penalties or criminal implications [...]
Apr282010
The U.S. Food and Drug Administration is considering whether to stop a safety study comparing Avandia to another diabetes medication. If the study is stopped, it is possible that the FDA will remove the drug from the market. It has been estimated that more than 200,000 people in the U.S. alone suffer serious, sometimes even [...]
